Cargando…

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

BACKGROUND: Patients with early stage papillary thyroid carcinoma (PTC), are faced with the decision to either to accept or reject adjuvant radioactive iodine (RAI) treatment after thryroidectomy. This decision is often difficult because of conflicting reports of RAI treatment benefit and medical ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawka, Anna M, Straus, Sharon, Brierley, James D, Tsang, Richard W, Rotstein, Lorne, Rodin, Gary, Gafni, Amiram, Ezzat, Shereen, Thabane, Lehana, Thorpe, Kevin E, Goldstein, David P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917435/ https://www.ncbi.nlm.nih.gov/pubmed/20659341 http://dx.doi.org/10.1186/1745-6215-11-81

Ejemplares similares

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension
por: Sawka, Anna M., et al.
Publicado: (2015)

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow‐up from a decision‐aid randomized trial
por: Sawka, Anna M., et al.
Publicado: (2015)

The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study
por: Sawka, Anna M., et al.
Publicado: (2009)

How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?
por: Sawka, A M, et al.
Publicado: (2011)

Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study
por: Sawka, A. M., et al.
Publicado: (2011)

Exploring the relationship between patients’ information preference style and knowledge acquisition process in a computerized patient decision aid randomized controlled trial
por: Sawka, Anna M., et al.
Publicado: (2015)

Current management of papillary thyroid microcarcinoma in Canada
por: Merdad, Mazin, et al.
Publicado: (2014)

Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
por: Sawka, Anna M, et al.
Publicado: (2005)

FRI525 Gender Differences In Fears Related To Low Risk Papillary Thyroid Cancer And Its Treatment
por: Sawka, Anna M, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism
por: Akirov, Amit, et al.
Publicado: (2019)

Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
por: Sawka, Anna M, et al.
Publicado: (2005)

A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma
por: Sawka, Anna M, et al.
Publicado: (2004)

A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer
por: Sawka, Anna M, et al.
Publicado: (2018)

Gender Differences in Fears Related to Low-Risk Papillary Thyroid Cancer and Its Treatment
por: Sawka, Anna M., et al.
Publicado: (2023)

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
por: Lau, Arthur N, et al.
Publicado: (2008)

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
por: Lukovic, Jelena, et al.
Publicado: (2021)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer
por: Sawka, Anna M., et al.
Publicado: (2020)

Patterns of regional recurrence in papillary thyroid cancer patients with lateral neck metastases undergoing neck dissection
por: Xu, Jason J., et al.
Publicado: (2017)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Decision-making in Surgery or Active Surveillance for Low Risk Papillary Thyroid Cancer During the COVID-19 Pandemic
por: Sawka, Anna M., et al.
Publicado: (2021)

The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020)

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
por: Sondorp, Luc H.J., et al.
Publicado: (2020)

“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015)

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
por: Tang, Jianing, et al.
Publicado: (2018)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine
por: Adamska, Agnieszka, et al.
Publicado: (2021)

Responses to the First Radioactive Iodine Treatment After Targeted Therapy for Aggressive Papillary Thyroid Cancers
por: Soe, Myat Han, et al.
Publicado: (2021)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
por: Li, Wanting, et al.
Publicado: (2023)

Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop
por: Sawka, Anna M, et al.
Publicado: (2008)

BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer
por: Han, Sang-Ah, et al.
Publicado: (2014)

SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents
por: Sawka, Anna M., et al.
Publicado: (2010)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2017)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mrmhs0om2c0gj9f5pj3ce9val3